Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00520286 · ClinicalTrials.gov registry record · Phase 2
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
A Phase 2 study of Methamphetamine-dependence, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 210
- Enrollment target
- 8
- Study locations
NCT00520286 is a Phase 2 study of Methamphetamine-dependence that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 210 participants, above the 95-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (121% higher). The trial reports 8 study locations across 6 states.
The verdict
NCT00520286, a Phase 2 study of Methamphetamine-dependence, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 210 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Modafinil
Study Locations (8)
California
- South Bay Treatment Center - San Diego
- Matrix Institute on Addictions - Tarzana
- Torrance Site - Torrance
Colorado
- University of Colorado Health Sciences Center - Denver
Hawaii
- John A. Burns School of Medicine - Honolulu
Iowa
- Powell Chemical Dependency Center - Des Moines
Missouri
- START Research and Treatment - Kansas City
Utah
- Salt Lake City VA Medical Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00520286
The ClinicalTrials.gov registry entry for NCT00520286 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 95-participant average among 18 other Methamphetamine-dependence trials with a reported enrollment target (121% higher). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methamphetamine-dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00520286 reports 8 study locations spanning 6 distinct geographic areas - top geographies include California, Colorado, Hawaii.
Frequently Asked Questions
What is clinical trial NCT00520286 about?
NCT00520286 is a clinical study titled "Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence". The purpose of this study will be to examine the safety and efficacy of modafinil in increasing number of methamphetamine non-use weeks in subjects with methamphetamine dependence.
What is the current status of trial NCT00520286?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 210 participants. The study started on 2007-12. Estimated completion is 2010-03.
What conditions does trial NCT00520286 study?
This clinical trial studies the following conditions: Methamphetamine-dependence.
What interventions are being tested in trial NCT00520286?
The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG).
Who is sponsoring clinical trial NCT00520286?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00520286 being conducted?
This trial has 8 study locations across California, Colorado, Hawaii, Iowa, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methamphetamine-dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
COMPLETED · Phase 2
-
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
COMPLETED · Phase 2
-
Study of Medical Treatment for Methamphetamine Addiction
COMPLETED · Phase 2
-
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
COMPLETED · Phase 2
-
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.